Table of Contents

Spondyloarthritis

• You have access

  One-Third of European Patients With Axial Spondyloarthritis Reach Pain Remission With Routine Care Tumor Necrosis Factor Inhibitor Treatment

  Lykke Midtbøll Ørnbjerg, Kathrine Rugbjerg, Stylianos Georgiadis, Simon Horskjær Rasmussen, Ulf Lindström, Karel Pavelka, Neslihan Yilmaz, Ennio Giulio Favalli, Michael J. Nissen, Brigitte Michelsen, Elsa Vieira-Sousa, Gareth T. Jones, Ruxandra Ionescu, Heikki Relas, Carlos Sanchez-Piedra, Matija Tomšič, Arni Jon Geirsson, Irene van der Horst-Bruinsma, Johan Askling, Anne Gitte Loft, Lucie Nekvindova, Haner Direskeneli, Florenzo Iannone, Adrian Ciurea, Karen Minde Fagerli, Maria José Santos, Gary J. Macfarlane, Catalin Codreanu, Kari Eklund, Manuel Pombo-Suarez, Ziga Rotar, Bjorn Gudbjornsson, Tamara Rusman, Mikkel Østergaard and Merete Lund Hetland

  The Journal of Rheumatology August 1 2023, 50 (8) 1009-1019; DOI: https://doi.org/10.3899/jrheum.220459
• Open Access

  Long-Term Safety and Efficacy of Ixekizumab in Patients With Axial Spondyloarthritis: 3-year Data From the COAST Program

  Atul Deodhar, Denis Poddubnyy, Proton Rahman, Jeorg Ermann, Tetsuya Tomita, Rebeca Bolce, Soyi Liu Leage, Andris Kronbergs, Caroline Johnson, Joana Araújo, Ann Leung and Désirée van der Heijde

  The Journal of Rheumatology August 1 2023, 50 (8) 1020-1028; DOI: https://doi.org/10.3899/jrheum.221022